CAMPUS Expanded "Classification and Assessment of Mental Health Performance Using Semantics Expanded"
Launched by CLARIGENT HEALTH · Jul 27, 2020
Trial Information
Current as of September 08, 2025
Recruiting
Keywords
ClinConnect Summary
The CAMPUS Expanded study is looking at ways to improve an app that helps identify early signs of mental health challenges and suicidal thoughts. Researchers want to collect data from people who are already getting support from mental health professionals at schools, outpatient clinics, or college counseling centers. This study aims to use this information to create better tools for recognizing when someone might be at risk for suicide or experiencing serious mental health issues like depression or anxiety.
To participate, you need to be at least 8 years old and currently receiving services from a mental health professional. You’ll also need to speak English and be able to give consent, or have a parent or guardian provide it for you. The study is open to everyone, regardless of gender, and is currently recruiting participants. If you join, you can expect to help researchers understand mental health better, which could lead to improved support for others in the future. However, individuals with certain communication issues or serious health conditions that might make participation difficult will not be eligible to take part.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Currently a client receiving services from a MHP at a school or outpatient setting, or at a college/university counseling center
- • Age ≥ 8 years old
- • Able to provide informed consent, parental permission or assent
- • English as a primary language
- Exclusion Criteria:
- • Participants with communication disorders (linguistic or articulation)
- • Any minor participants for whom parental or legal guardian consent cannot be obtained.
- • Any adult participant for whom Legal Authorized Representative (LAR) consent cannot be obtained.
- • History of any other serious medical or psychiatric condition that would interfere with the ability of the patient to complete the study or would make it ethically unfeasible to enroll them
- • Participants with an intellectual and / or neurocognitive disability that the MHP deems a barrier to participation
- • Any participant, who at the discretion of the MHP, should not be enrolled
About Clarigent Health
Clarigent Health is a pioneering clinical trial sponsor focused on advancing mental health diagnostics and treatment through innovative technologies. By leveraging artificial intelligence and data-driven methodologies, Clarigent Health aims to enhance the accuracy of mental health assessments and improve patient outcomes. The organization collaborates with healthcare professionals and research institutions to develop evidence-based solutions that address the complexities of mental health disorders, ultimately striving to transform the landscape of mental healthcare. With a commitment to rigorous clinical research and ethical standards, Clarigent Health is dedicated to driving progress in the field of mental health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Mason, Ohio, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials